Search Videos and More
Video
Urinary Incontinence in Women: Evaluation and Management
Dr. Joshua Cohn, Fox Chase-Temple Urologic Institute Provider, discusses urinary incontinence in women, focusing on the etiology, prevalence and diagnostic evaluation. He also discusses the various treatment options that may be most helpful for each patient.
News
Comprehensive Cancer Care Demands Exceptional Teamwork, Collaboration and Leaders to Bring It to Life.
Centralizing scientific discovery, advanced research, and clinical care—all for a new therapeutic pathway.
News
New Fox Chase Clinical Trial Could Help Men With Intermediate-Risk Prostate Cancer Avoid Radical Treatment
Could NanoKnife be the future of prostate cancer care?
News
A Salvage Treatment Jennifer Was Inspired to Salvage.
A Life-Saving Idea for Bladder Cancer Patients.
News
Fox Chase Cancer Center Researchers Present Further Data on Potential Bladder-Sparing Treatment
Bladder removal is life-altering. This study examines when and why some patients may not need it.
Symposium
Optimizing Treatment Strategies for Localized and Advanced Prostate Cancer
View this symposium presented by Fox Chase Cancer Center and the Temple Health Office for Continuing Medical Education. Learn the most current strategies for optimally managing localized and advanced prostate cancer from the Fox Chase Cancer Center genitourinary oncology team—nationally recognized physicians specializing in urology, radiation therapy, medical oncology, and radiology
News
Cancer Is a Moving Target.
CBCT-Based Adaptive Radiation Therapy Tracks It Every Day of Treatment.
News
The New Department of Urology at Fox Chase Cancer Center
Built on strength: world-class specialists, innovative researchers, and clinical leaders.
News
Transforming Cancer Care and Delivery
The new President and CEO of Fox Chase Cancer Center
News
Dr. Laura Bukavina on the Front Lines of Research and War
Fighting for life everywhere she goes.
Video
What is the Same and What Has Changed with the Artificial Urinary Sphincter?
The artificial urinary sphincter is an implantable device designed to treat incontinence in prostate cancer survivors. The device has existed for 50 years, and in that time, best practices around its use have undergone several paradigm shifts.
News
Fox Chase Urology Just Took a Big Leap Forward
A new benign urology team adds gravitas to a renowned cancer department.